Cannabist Co Holdings Inc. Files 8-K on Key Agreements
Ticker: CBSTF · Form: 8-K · Filed: Jul 2, 2024 · CIK: 1776738
| Field | Detail |
|---|---|
| Company | Cannabist Co Holdings Inc. (CBSTF) |
| Form Type | 8-K |
| Filed Date | Jul 2, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $15 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, shareholder-vote, corporate-action
TL;DR
Cannabist Co Holdings Inc. filed an 8-K on June 26, 2024, for material agreements and shareholder votes.
AI Summary
On June 26, 2024, The Cannabist Company Holdings Inc. filed an 8-K report detailing a material definitive agreement and submission of matters to a vote of security holders. The company, formerly known as Columbia Care Inc., is incorporated in British Columbia and has its principal executive offices in New York.
Why It Matters
This filing indicates significant corporate actions and potential changes that could impact the company's structure, operations, or shareholder rights.
Risk Assessment
Risk Level: medium — Material definitive agreements and votes of security holders can introduce significant changes and potential risks related to corporate governance and business operations.
Key Players & Entities
- Cannabist Co Holdings Inc. (company) — Filer
- Columbia Care Inc. (company) — Former company name
- June 26, 2024 (date) — Date of earliest event reported
- 2125543424 (phone_number) — Business phone number
FAQ
What specific material definitive agreement was entered into by Cannabist Co Holdings Inc. on June 26, 2024?
The filing states that an "Entry into a Material Definitive Agreement" is an item of disclosure, but the specific details of the agreement are not provided in this summary.
What matters were submitted to a vote of security holders?
The filing indicates that "Submission of Matters to a Vote of Security Holders" is an item of disclosure, but the specific matters are not detailed in this summary.
When was the company formerly known as Columbia Care Inc.?
The company was formerly known as Columbia Care Inc. prior to a name change on May 14, 2019.
What is the principal executive office address for Cannabist Co Holdings Inc.?
The principal executive offices are located at 680 Fifth Ave., 24th Floor, New York, New York 10019.
What is the SIC code for Cannabist Co Holdings Inc.?
The Standard Industrial Classification (SIC) code is 0100, which corresponds to AGRICULTURE PRODUCTION - CROPS.
Filing Stats: 862 words · 3 min read · ~3 pages · Grade level 13.4 · Accepted 2024-07-02 16:06:01
Key Financial Figures
- $15 million — he Holders may transfer an aggregate of $15 million principal amount of Notes in considerat
Filing Documents
- d859505d8k.htm (8-K) — 36KB
- 0001193125-24-174319.txt ( ) — 149KB
- ck0001776738-20240626.xsd (EX-101.SCH) — 2KB
- ck0001776738-20240626_lab.xml (EX-101.LAB) — 16KB
- ck0001776738-20240626_pre.xml (EX-101.PRE) — 10KB
- d859505d8k_htm.xml (XML) — 3KB
From the Filing
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 26, 2024 THE CANNABIST COMPANY HOLDINGS INC. (Exact Name of Registrant as specified in its charter) British Columbia 000-56294 98-1488978 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 680 Fifth Ave. , 24th Floor New York , New York 10019 (Address of principal executive offices) (Zip Code) ( 212 ) 634-7100 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: None. Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging Growth Company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. Item1.01. Entry into a Material Definitive Agreement. On June 30, 2024, The Cannabist Company Holdings Inc. (the "Company") entered into an amendment (the "Amendment") to the exchange agreement (the "Exchange Agreement"), dated January 22, 2024, with certain holders (the "Holders") of the Company's 6.0% senior secured convertible notes due June 2025 (the "Notes"), pursuant to which the parties agreed to extend the period in which the Holders may transfer an aggregate of $15 million principal amount of Notes in consideration of common shares of the Company to September 30, 2024. The parties also agreed to extend the term of the Exchange Agreement to October 31, 2024. Item 1.01 of this Current Report on Form 8-K contains only a brief description of the material terms of and does not purport to be a complete description of the rights and obligations of the parties to the Amendment, and such description is qualified in its entirety by reference to the full text of the Amendment, which will be filed with the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. Item5.07. Submission of Matters to a Vote of Security Holders. At the annual general meeting of shareholders of the Company held virtually at 11:00 a.m. (Toronto time) on June 26, 2024 (the "Meeting"), the Company's shareholders voted on the following proposals, which are described in detail in the Company's definitive proxy statement and information circular filed with the United States Securities and Exchange Commission on June 4, 2024 (the "Circular"): (i) to elect nine (9) directors to serve on the Company's board of directors until the next annual meeting of shareholders or until their successors are duly elected or appointed ("Proposal 1"), and (ii) to re-appoint Davidson & Company LLP as the auditor of the Company to hold office until the next annual meeting of shareholders and to authorize the directors of the Company to fix the auditor's remuneration ("Proposal 2"). Set forth below are the final voting results with respect to each of the proposals acted upon at the Meeting, including the number of votes cast for and against (or withheld), and the number of abstentions and broker non-votes with respect to each such proposal. Proposal 1: Election of Directors At the Meeting, each of the following nine (9) nominees were elected to serve on the Company's board of directors until the next annual meeting of shareholders or until their successors are duly elected or appointed, by a vote held by ballot in respect of each nominee as follows: DIRECTORS FOR WITHHELD BROKER NON-VOTES David Hart 109,330,401 5,439,846 68,205,308 Michael Abbott 91,126,342 23,643,905 68,205,308 Frank Savage 97,100,499 17,669,748 68,205,308 James A.C. Kennedy 106,518,131 8,252,116 68,205,308 Jonathan P. May 106,509,789 8,260,458 68,205,308 Jeff Clarke 106,514,168 8,256,079 68,205,308 Alison Worthington 106,509,294 8,260,953 68,205,308 Julie Hill 105,246,123 9,524,124 68,205,308 Rosemary Mazanet 98,544,023 16,226,224 68,205,308 Proposal 2: Re-appointment of Auditor At the Meeting, the shareho